Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245167 · ClinicalTrials.gov registry record
Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 120
- Enrollment target
NCT00245167 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 120 participants.
The verdict
NCT00245167 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The first objective of this study is to determine if increased expression of one or more members of the toll-like receptor (TLR) family of receptors that are found on inflammatory cells (present in the airway) precede development of chronic lung disease (CLD) of prematurity. The study will also determine if there is a significant correlation between TLRs and the severity of CLD. The second objective of this study is to determine the impact of c-administration of inhaled nitric oxide (INO) on TLR expression in infants at risk of developing CLD or with early CLD.
Interventions
- PROCEDURE Tracheal Aspirate Fluid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2002-01 |
| Est. Completion | 2006-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00245167
The ClinicalTrials.gov registry entry for NCT00245167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tracheal Aspirate Fluid is the first listed.
NCT00245167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00245167 about?
NCT00245167 is a clinical study titled "Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease". The first objective of this study is to determine if increased expression of one or more members of the toll-like receptor (TLR) family of receptors that are found on inflammatory cells (present in the airway) precede development of chronic lung disease (CLD) of prematurity. The study will also dete...
What is the current status of trial NCT00245167?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2002-01. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00245167?
The interventions under investigation include: Tracheal Aspirate Fluid (PROCEDURE).
Who is sponsoring clinical trial NCT00245167?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.